MedPath

Haloperidol

Haloperidol Injection, USP

Approved
Approval ID

a9970612-0ab3-4a8b-ae84-231738d913a4

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 16, 2021

Manufacturers
FDA

Fresenius Kabi USA, LLC

DUNS: 608775388

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

haloperidol lactate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code76045-737
Application NumberANDA210356
Product Classification
M
Marketing Category
C73584
G
Generic Name
haloperidol lactate
Product Specifications
Route of AdministrationINTRAMUSCULAR
Effective DateNovember 30, 2019
FDA Product Classification

INGREDIENTS (2)

Haloperidol lactateActive
Quantity: 5 mg in 1 mL
Code: 6387S86PK3
Classification: ACTIM
LACTIC ACID, UNSPECIFIED FORMInactive
Code: 33X04XA5AT
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Haloperidol - FDA Drug Approval Details